We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$46.6B
AUM Growth
-$1.27B
(-2.6%)
Cap. Flow
-$2.28B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
19.53%
Holding
1,157
New
166
Increased
296
Reduced
323
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$208M |
| 2 |
Mastercard
MA
|
+$198M |
| 3 |
Kinder Morgan
KMI
|
+$174M |
| 4 |
Parker-Hannifin
PH
|
+$170M |
| 5 |
Check Point Software Technologies
CHKP
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$247M |
| 2 |
Pfizer
PFE
|
+$179M |
| 3 |
DuPont de Nemours
DD
|
+$149M |
| 4 |
Credicorp
BAP
|
+$138M |
| 5 |
McKesson
MCK
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.46% |
| 2 | Communication Services | 14.94% |
| 3 | Technology | 11.88% |
| 4 | Financials | 10.97% |
| 5 | Energy | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Honeywell
HON
$77.1B
| $437M | 0.94% |
5,216,859
+505,038
| +11% | +$42.9M |
|
27
UnitedHealth
UNH
$382B
| $430M | 0.92% |
4,984,019
-141,362
| -3% | -$11.9M |
|
28
American Express
AXP
$223B
| $419M | 0.9% |
4,791,219
+553,707
| +13% | +$49.8M |
|
29
PG&E
PCG
$47.8B
| $415M | 0.89% |
9,207,264
+506,473
| +6% | +$23.3M |
|
30
Baxter International
BAX
$11.6B
| $412M | 0.88% |
10,560,311
+1,040,651
| +11% | +$42.3M |
|
31
Eastman Chemical
EMN
$7.8B
| $400M | 0.86% |
4,943,314
-174,245
| -3% | -$14.5M |
|
32
Eli Lilly
LLY
$1.07T
| $383M | 0.82% |
5,905,296
-529,662
| -8% | -$33.5M |
|
33
Xerox
XRX
$337M
| $380M | 0.82% |
10,887,522
+2,043,216
| +23% | +$71.3M |
|
34
Vale
VALE
$62.9B
| $373M | 0.8% |
33,876,710
+2,440,022
| +8% | +$32.6M |
|
|
35
McKesson
MCK
$98.5B
| $368M | 0.79% |
1,891,831
-696,354
| -27% | -$134M |
|
36
Sysco
SYY
$39.7B
| $365M | 0.78% |
9,605,427
-2,070,688
| -18% | -$77.3M |
|
37
Amgen
AMGN
$203B
| $330M | 0.71% |
2,350,728
-216,062
| -8% | -$28.2M |
|
38
APA Corp
APA
$12.8B
| $327M | 0.7% |
3,484,882
-736,767
| -17% | -$73M |
|
39
Norfolk Southern
NSC
$78.8B
| $326M | 0.7% |
2,924,082
-133,903
| -4% | -$14.2M |
|
|
CFN
40
DELISTED
CAREFUSION CORPORATION
CFN
| $315M | 0.68% |
6,955,040
+200,238
| +3% | +$9.02M |
|
|
MON
41
DELISTED
Monsanto Co
MON
| $309M | 0.66% |
2,742,629
-206,639
| -7% | -$24.2M |
|
42
CEMIG Preferred Shares
CIG
$6.09B
| $301M | 0.65% |
94,780,588
+4,746,199
| +5% | +$19.5M |
|
43
Intercontinental Exchange
ICE
$82.4B
| $300M | 0.65% |
7,700,305
+21,780
| +0.3% | +$835K |
|
44
Vertex Pharmaceuticals
VRTX
$121B
| $284M | 0.61% |
2,524,532
-102,657
| -4% | -$9.77M |
|
45
CVS Health
CVS
$137B
| $277M | 0.59% |
3,477,464
-482,759
| -12% | -$38.1M |
|
46
Johnson & Johnson
JNJ
$635B
| $275M | 0.59% |
2,580,993
-295,260
| -10% | -$30.6M |
|
47
EOG Resources
EOG
$78B
| $274M | 0.59% |
2,768,173
+222,045
| +9% | +$24.1M |
|
48
Oracle
ORCL
$331B
| $269M | 0.58% |
7,031,507
-820,476
| -10% | -$33.2M |
|
49
Hartford Financial Services
HIG
$38.5B
| $268M | 0.58% |
7,195,263
-293,763
| -4% | -$10.6M |
|
|
50
Check Point Software Technologies
CHKP
$13.3B
| $266M | 0.57% |
3,839,919
+2,119,459
| +123% | +$144M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, Lazard Asset Management held 1,157 positions worth $46.6B, down 2.6% from $47.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lazard Asset Management withdrew a net $2.28B in Q3 2014, closing 125 positions and reducing 323 holdings. Its most notable exit was TYCO INTL PLC COM SHS (IRL), an estimated $247M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Lazard Asset Management opened a new position in Mastercard worth $193M.
- Lazard Asset Management's largest Q3 2014 buy was Mastercard: 2,605,801 shares worth $193M.
- Lazard Asset Management added most to Viatris in Q3 2014, an estimated $208M increase.
- Lazard Asset Management's biggest Q3 2014 reduction was Pfizer, cutting an estimated $179M.
- Lazard Asset Management fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2014, selling an estimated $247M.
- Lazard Asset Management's ten largest holdings make up 20% of its $46.6B portfolio in Q3 2014.
- Lazard Asset Management opened 166 new positions and closed 125 in Q3 2014.
- Lazard Asset Management's portfolio value fell 2.6% quarter-over-quarter to $46.6B.
Based on Lazard Asset Management's 13F filing for Q3 2014, filed 7 Nov 2014.